Preclinical research in murine senescence models has examined FOXO4-DRI for its capacity to reduce senescent cell burden, with observed improvements in physical function, coat density, and renal histology endpoints in aged subjects
Required Medical Stability: Patients must not have decompensated neurological conditions (e.g., advanced multiple sclerosis or Parkinsons disease), as these may affect the therapys ability to restore normal sleep patterns
I hold additional qualifications in Sports and Exercise Medicine from Barts and The London School of Medicine and Dentistry (Queen Mary University of London), and in Diabetes Care from Warwick Medical School
Researchers working with GHK-Cu often work alongside the following compounds in the preclinical literature: References are independent peer-reviewed sources
Areas of Current Research PDA (BPC-157-Arginine) continues to be investigated across several areas of regenerative and gastrointestinal medicine
Is it safe to use 25% Vitamin C + Glutathione Clinical Serum during pregnancy or while breastfeeding